Determining the Dose Response Profile of the Headward Fluid Shift During Varying Gravity Levels
AG2
1 other identifier
interventional
9
1 country
1
Brief Summary
Parabolic flight provides a unique opportunity to evaluate the acute changes associated with varying levels of gravity and to describe how key venous parameters change at levels less than normal Earth gravity. Characterizing these changes in response to varying G-levels is an important step in determining what G-level may be required to reverse weightlessness-induced fluid shifts and thus serve as a viable countermeasure during long-duration spaceflight. Further, these results will inform National Aeronautics and Space Administration (NASA) whether there might be a lower risk of Spaceflight Associated Neuro-ocular Syndrome (SANS) and Venous Thromboembolism (VTE) during extended stays on the Moon and Mars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Jul 2022
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2024
CompletedFirst Submitted
Initial submission to the registry
July 8, 2024
CompletedFirst Posted
Study publicly available on registry
July 15, 2024
CompletedSeptember 19, 2024
July 1, 2024
11 months
July 8, 2024
September 6, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Bilateral Internal jugular vein blood flow characterization
ultrasound measures of the bilateral Internal jugular vein with numeric blood flow characterization
2-3 hours
Bilateral Internal jugular vein pressure
ultrasound measures of the bilateral Internal jugular vein using a pressure measurement device
2-3 hours
Bilateral Internal jugular vein area
ultrasound measures of the bilateral Internal jugular vein to measure vein area
2-3 hours
Study Arms (3)
Preflight Seated
NO INTERVENTIONPreflight control at 1 Gravity level (G), seated. Data collection of Internal Jugular Vein (IJV) area, IJV pressure, and Doppler blood flow.
Preflight Supine
NO INTERVENTIONPreflight control at 1 Gravity level (G), supine. Data collection of Internal Jugular Vein (IJV) area, IJV pressure, and Doppler blood flow.
inflight reduced gravity measures
EXPERIMENTALinflight experimental at 0 Gravity levels (G), 0.25G, 0.5G, and 0.75G. Data collection of Internal Jugular Vein (IJV) area, IJV pressure, and Doppler blood flow.
Interventions
The aircraft will fly in parabolas that initially produce increased gravity (1.8-G, "hypergravity"), followed by \~20-50 second periods of partial gravity or weightlessness. Flights which produce partial gravity (0.25-, 0.50-, and 0.75-gravity) generally will consist of 31 parabolas (at least 10 parabolas at each gravity level), and flights that produce weightlessness generally will consist of 16 parabolas.
Eligibility Criteria
You may qualify if:
- In coordination with the parabolic flight company, Novespace, healthy volunteers from the population that are 25-55 years old without a history cardiovascular disease will be recruited for this study. In order to participate, subjects must be able to follow instructions in English.
- Participants must be age 18 years or older, hold a French or European Health Insurance Card, and provide medical certification of fitness for flight to NOVESPACE (i.e., NOVESPACE Parabolic Flight Medical Aptitude Certificate) completed by their medical doctor or an Authorized Medical Examiner.
- Participants must meet medical criteria and provide certification of fitness for flight to NOVESPACE (i.e. NOVESPACE Parabolic Flight Medical Aptitude Certificate) completed by their medical doctor or an Authorized Medical Examiner.
You may not qualify if:
- Those with certain heart and lung conditions
- dizziness
- certain inner ear conditions
- severe motor disability or impaired bone density
- psychosis
- mental disability prohibiting emergency evacuation
- epilepsy
- certain neurological diseases
- fear of heights/flying
- debilitating anxiety and panic attacks
- claustrophobia, women who are pregnant
- certain gastrointestinal conditions
- those taking certain medications are ineligible to participate
- An individual's overall medical fitness for flight is assessed and certified by a medical doctor or Authorized Medical Examiner.
- Pregnant women are not eligible to participate in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Aeronautics and Space Administration (NASA)lead
- NOVESPACE (Merignac, France)collaborator
- European Space Agencycollaborator
Study Sites (1)
NASA
Houston, Texas, 77058, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stuart M Lee, PhD
National Aeronautics and Space Administration (NASA)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2024
First Posted
July 15, 2024
Study Start
July 21, 2022
Primary Completion
June 15, 2023
Study Completion
April 17, 2024
Last Updated
September 19, 2024
Record last verified: 2024-07